SCHEMBL19190876

SCHEMBL19190876

COc1cnc2ccc(C(F)(F)C(=N)n3cc(-c4cc(C)no4)cc(F)c3=N)cc2c1

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MET P08581 18/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19191432 0.83 MET (0.61) MET
SCHEMBL18885868 0.83 MET (0.62) MET
SCHEMBL18885818 0.82 MET (0.44) MET
SCHEMBL18885688 0.77 MET (0.45) MET
SCHEMBL9910493 0.77 MET (1.00) MET
SCHEMBL10242446 0.75 MET (1.00) MET
SCHEMBL19190579 0.72 MET (0.48) MET
SCHEMBL13772558 0.71 MET (0.50) MET
SCHEMBL19190665 0.68 MET (0.50) MET
SCHEMBL9910450 0.68 MET (1.00) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231663-B1 6-([1,2,4]TRIAZOLO[4,3-A]PYRIDIN-3-YLMETHYL)-1,6-NAPHTHYRIDIN-5(6H)-ONE DERIVATIVES AS C-MET INHIBITORS AMGEN INC (US) 2017-08-02 EP disclosed